Vimarsana
Biggest News Aggregation in the World

Page 11 - Multiple System News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Multiple System. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Multiple System Today - Breaking & Trending Today

Alterity Gets FDA Nod To Conduct Phase 2 Trial Of ATH434 In Multiple System Atrophy - Vimarsana News

Alterity Gets FDA Nod To Conduct Phase 2 Trial Of ATH434 In Multiple System Atrophy

(RTTNews) - Alterity Therapeutics Ltd. (ATHE), a company focused on neurodegenerative diseases, said on Tuesday that it has received FDA clearance...

Amprion Exhibits at MDS International Congress of Parkinson's Disease and Movement Disorders in Madrid and Presents Scientific Insights On SYNTap® Test at Prion2022 - Vimarsana News

Amprion Exhibits at MDS International Congress of Parkinson's Disease and Movement Disorders in Madrid and Presents Scientific Insights On SYNTap® Test at Prion2022

San Francisco CA (PRWEB) September 15, 2022 -- Amprion, a leader in diagnostics for neurodegenerative diseases, invites researchers and practitioners

Source: prweb.com
Coave Therapeutics to Collaborate with World-Renowned Institute of Neurodegenerative Diseases of Bordeaux to Develop Gene Therapy Programs Targeting Protein Degradation in Neurodegenerative Disorders - Vimarsana News

Coave Therapeutics to Collaborate with World-Renowned Institute of Neurodegenerative Diseases of Bordeaux to Develop Gene Therapy Programs Targeting Protein Degradation in Neurodegenerative Disorders

/PRNewswire/ -- Coave Therapeutics ('Coave'), a clinical-stage biotechnology company focused on developing life-changing gene therapies for CNS (Central...

Inhibikase Therapeutics Reports Second Quarter 2022 Financial Results and Highlights Recent Period Activity - Vimarsana News

Inhibikase Therapeutics Reports Second Quarter 2022 Financial Results and Highlights Recent Period Activity

/PRNewswire/ -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) ("Inhibikase" or "Company"), a clinical-stage pharmaceutical company developing therapeutics with...

Inhibikase Therapeutics Reports Second Quarter 2022 Financial Results and Highlights Recent Period Activity - Press Release - Vimarsana News

Inhibikase Therapeutics Reports Second Quarter 2022 Financial Results and Highlights Recent Period Activity - Press Release

Company to host conference call and webcast on Monday, August 15, 2022, at 8:00am ETBOSTON and ATLANTA, Aug. 12, 2022 /PRNewswire/ -- Inhibikase Thera